K+ontrol renal support system for reduction of hyperkalemia - RIF
Ended Definitive Contract Awarded Last action
- Contract number
- FA865019C6065
- Awardee
-
Cytosorbents Medical Inc. UEI LSF2KFUSY4K7 Part of Cytosorbents Corporation
- Awarding agency
-
Air Force Research Laboratory
Air Force Materiel Command, Department of Defense
- Obligated
- $2,849,920
Award facts
- Opportunity
-
- HQ003418BAARI Solicitation number
- K+ontrol Renal Support System for Reduction of Hyperkalemia Award Notice · Posted Sep 26, 2019
- Contract value 96% obligated
- $2,959,747.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Air Force Department of Defense
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 6 offers Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Princeton, NJ, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | -$109,827 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Other Administrative Action | $0 | |
| Original award | $2,959,747 |
About this award
The Air Force has awarded a $2,959,747 cost-plus-fixed-fee contract to Cytosorbents Medical Inc. to provide the K+ONTROL Renal Support System for Reduction of Hyperkalemia. This definitive contract has an ultimate completion date of September 27, 2023. Cytosorbents is a for-profit manufacturer that develops blood purification technologies to treat critical care conditions. The company has previously received research and development funding from the National Institutes of Health and Department of the Army to advance its medical device technologies. This contract award does not have a set-aside designation.
Quick answers
Who was awarded contract FA865019C6065?
FA865019C6065 was awarded to Cytosorbents Medical Inc. by Air Force Research Laboratory (Air Force Materiel Command) on September 24, 2019.
How much is contract FA865019C6065 worth?
The government has obligated $2,849,920 on FA865019C6065. Its current value, with exercised options, is $2,959,747.
Which agency awarded contract FA865019C6065?
Air Force Research Laboratory (Air Force Materiel Command) awarded FA865019C6065, with funding from Air Force (Department of Defense).
Was contract FA865019C6065 competed?
The extent of competition for FA865019C6065 was full and open competition. The government received 6 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award